Univest
Univest
  • Markets

Shilpa Medicare Share Price Target 2026: Expert Forecast, Catalysts and Key Risks

  • May 12, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Shilpa Medicare Share Price Target 2026

The Shilpa Medicare share price target for 2026 stands at Rs 824 as per analyst forecast implying 20 to 40 percent upside from the current market price of Rs 680. Investors tracking the Shilpa Medicare share price target 2026 need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the Shilpa Medicare share price target thesis updated April 2026.

Click Here Get Free Investment Predictions on Univest

Track live Shilpa Medicare price, FII/DII flows and analyst targets on the Univest Screener.

Table of Contents

Toggle
  • Shilpa Medicare Company Overview
  • Why Is Shilpa Medicare Share Price Target Set at Rs 824 for 2026
    • FY27 Earnings Delivery and Revenue Acceleration
    • Structural Sector Tailwinds in Pharmaceuticals API Oncology
    • RBI Rate Cut Cycle and Improving Macro Backdrop
    • Union Budget 2026 Policy Support
    • Improving FII Flows Post US Tariff Shock
  • Shilpa Medicare Share Price Targets Short Term 12 Month and Long Term
    • Short Term Shilpa Medicare Share Price Target 3 to 6 Months
    • 12 Month Shilpa Medicare Share Price Target 2026
    • Long Term Shilpa Medicare Share Price Target FY27 to FY28
  • Bull Case and Bear Case for Shilpa Medicare Share Price Target
    • Bull Case Shilpa Medicare Share Price Target Rs 1,058
    • Bear Case Shilpa Medicare Share Price Target Rs 496
  • Key Risks to the Shilpa Medicare Share Price Target 2026
    • US Tariff Macro Headwind
    • Valuation and Earnings Miss Risk
    • Competitive Pressure in Pharmaceuticals API Oncology
    • FII Selling Pressure and Currency Risk
  • How to Invest in Shilpa Medicare
  • FAQs on Shilpa Medicare Share Price Target 2026
    • What is the Shilpa Medicare share price target for 2026?
    • Is Shilpa Medicare a good buy at CMP Rs 680?
    • What are the main risks to the Shilpa Medicare share price target?
    • What are the key catalysts for the Shilpa Medicare share price target?
    • What is the Shilpa Medicare share price target for 2027?
    • Where can I track Shilpa Medicare live analyst targets?
    • What is Shilpa Medicare 52 week high and low?
    • How to buy Shilpa Medicare shares?
  • Recent Article

Shilpa Medicare Company Overview

Tap to Access Best Research Pieces on Univest

Shilpa Medicare (NSE: SHILPAMED) is a listed company in India’s Pharmaceuticals API Oncology sector with a market capitalisation of Rs 3,500 crore. At CMP Rs 680 against a 52 week range of Rs 500 to Rs 1,000, the stock currently offers meaningful upside to the analyst forecast Shilpa Medicare share price target of Rs 824. For more share price target analysis, visit Univest Blogs.

Parameter Value
NSE Ticker SHILPAMED
Sector Pharmaceuticals API Oncology
CMP April 2026 Rs 680
52 Week High Rs 1,000
52 Week Low Rs 500
Market Cap Rs 3,500 crore
Trailing P/E 28x
12M Analyst Target Rs 824
Bull Case Target Rs 1,058
Bear Case Target Rs 496

Why Is Shilpa Medicare Share Price Target Set at Rs 824 for 2026

FY27 Earnings Delivery and Revenue Acceleration

FY27 is the year where analysts expect Shilpa Medicare to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 680 and the Shilpa Medicare share price target 2026 of Rs 824. Analysts project 15 to 20 percent PAT growth in FY27. Q4 FY26 results with positive FY27 guidance are the immediate trigger for re-rating toward the Shilpa Medicare share price target forecast. Track Q4 results live on the Univest Screener.

Structural Sector Tailwinds in Pharmaceuticals API Oncology

India’s Pharmaceuticals API Oncology sector is expanding at 12 to 18 percent annually driven by urbanisation, rising incomes, government policy continuity, and the broad India growth narrative. Shilpa Medicare’s market position within this expanding sector creates compounding runway that directly supports the Shilpa Medicare share price target forecast of Rs 824. Discover top stocks on the Univest Screener.

RBI Rate Cut Cycle and Improving Macro Backdrop

India’s RBI rate cut cycle which commenced in 2026 reduces Shilpa Medicare’s borrowing costs and stimulates end customer demand. Lower interest rates improve EBITDA to PAT conversion, directly expanding EPS and supporting the Shilpa Medicare share price target 2026 of Rs 824. Compare Shilpa Medicare with sector peers live on the Univest Screener.

Union Budget 2026 Policy Support

Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, continued PLI scheme support, and consumption demand incentives create a positive policy backdrop for Shilpa Medicare’s Pharmaceuticals API Oncology business, directly supporting the Shilpa Medicare share price target 2026 bull case.

Improving FII Flows Post US Tariff Shock

As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian companies are expected to recover through FY27, directly supporting the Shilpa Medicare share price target of Rs 824. Track live FII/DII activity on the Univest Screener.

Shilpa Medicare Share Price Targets Short Term 12 Month and Long Term

Download the Univest iOS App or Univest Android App to get daily stock recommendations and SEBI registered research.

Short Term Shilpa Medicare Share Price Target 3 to 6 Months

The short term Shilpa Medicare share price target is anchored to the 52 week low support zone near Rs 500. Subscribe to Univest Pro for SEBI registered entry, target, and stop loss recommendations on Shilpa Medicare.

12 Month Shilpa Medicare Share Price Target 2026

The 12 month analyst forecast Shilpa Medicare share price target 2026 is Rs 824 implying 20 to 40 percent upside from CMP Rs 680. Track live targets on the Univest Screener.

Long Term Shilpa Medicare Share Price Target FY27 to FY28

For investors with a 2 to 3 year horizon, the long term Shilpa Medicare share price target is Rs 1,058 in the bull case. For more analysis, visit Univest Blogs.

Bull Case and Bear Case for Shilpa Medicare Share Price Target

Bull Case Shilpa Medicare Share Price Target Rs 1,058

The bull case for the Shilpa Medicare share price target of Rs 1,058 materialises if FY27 earnings exceed forecast and the Pharmaceuticals API Oncology sector benefits from a broad FII driven re-rating. Discover top stocks and live analyst targets on the Univest Screener.

Bear Case Shilpa Medicare Share Price Target Rs 496

The bear case sees the Shilpa Medicare share price target testing Rs 496 if FY27 guidance disappoints significantly and FII outflows from India persist. Track support levels on the Univest Screener.

Scenario Price Target Conditions
Bull Case Rs 1,058 FY27 beat, macro normalisation, sector re-rating, strong FII inflows
Base Case Forecast Rs 824 In line FY27 earnings, tariff resolution, FII recovery to neutral
Bear Case Rs 496 FY27 guidance cut, persistent FII outflows, sector de-rating

Key Risks to the Shilpa Medicare Share Price Target 2026

US Tariff Macro Headwind

The 26 percent US reciprocal tariff announced April 2, 2026 created FII outflow pressure across all Indian equities including Shilpa Medicare. This is the key downside risk to the Shilpa Medicare share price target 2026 forecast of Rs 824. Monitor trade developments live on the Univest Screener.

Valuation and Earnings Miss Risk

At 28x P/E, Shilpa Medicare is priced for consistent execution. Any earnings miss or guidance cut creates disproportionate de-rating risk, the most immediate risk to the Shilpa Medicare share price target 2026 of Rs 824. Track earnings on the Univest Screener.

Competitive Pressure in Pharmaceuticals API Oncology

Intensifying competition in Pharmaceuticals API Oncology may compress Shilpa Medicare’s pricing power and market share over the medium term. Subscribe to Univest Pro for SEBI registered research on Shilpa Medicare.

FII Selling Pressure and Currency Risk

Global risk off events can trigger institutional selling, disconnecting price from fundamental value. Track live FII/DII flows on the Univest Screener.

How to Invest in Shilpa Medicare

  1. Research on Univest Screener: Search SHILPAMED at univest.in/screeners for live fundamentals and the latest Shilpa Medicare share price target data.
  2. Open a Demat Account: Buy Shilpa Medicare (SHILPAMED) through any SEBI registered broker. Start on Univest here.
  3. Plan Your Entry: Key support near Rs 500. First resistance at the lower bound of the Shilpa Medicare share price target range of Rs 824.
  4. Position Sizing: Allocate maximum 3 to 5 percent of your portfolio to any single stock.
  5. Monitor: Download the Univest App for SEBI registered analyst research alerts on the Shilpa Medicare share price target.

FAQs on Shilpa Medicare Share Price Target 2026

What is the Shilpa Medicare share price target for 2026?

The Shilpa Medicare share price target 2026 is Rs 824 based on analyst forecast. Bull case is Rs 1,058, bear case is Rs 496. Track live on the Univest Screener.

Is Shilpa Medicare a good buy at CMP Rs 680?

At Rs 680, Shilpa Medicare offers potential upside to the Shilpa Medicare share price target 2026 of Rs 824. Depends on your risk tolerance and horizon. Get free research on Univest.

What are the main risks to the Shilpa Medicare share price target?

Key risks to the Shilpa Medicare share price target of Rs 824 include US tariff macro headwinds, valuation at 28x P/E, competitive dynamics in Pharmaceuticals API Oncology, and FII selling. Track on the Univest Screener.

What are the key catalysts for the Shilpa Medicare share price target?

Primary catalysts for the Shilpa Medicare share price target 2026 include Q4 FY26 results with positive FY27 guidance, RBI rate cuts, Union Budget policy support, and FII flow recovery. Track live on the Univest Screener.

What is the Shilpa Medicare share price target for 2027?

For FY27 to FY28, analysts project the Shilpa Medicare share price target toward Rs 1,058 in the bull case. Consult a SEBI registered financial advisor.

Where can I track Shilpa Medicare live analyst targets?

Track the Shilpa Medicare share price target live at univest.in/screeners. Download the Univest Android App or Univest iOS App.

What is Shilpa Medicare 52 week high and low?

Shilpa Medicare’s 52 week high is Rs 1,000 and 52 week low is Rs 500. The current CMP of Rs 680 offers potential upside to the analyst forecast Shilpa Medicare share price target 2026 of Rs 824.

How to buy Shilpa Medicare shares?

Buy Shilpa Medicare (SHILPAMED) through any SEBI registered broker on NSE. Research the Shilpa Medicare share price target on the Univest Screener and download the Univest App for SEBI registered analyst research alerts.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of April 2026. Consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.

Recent Article

Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026

Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026

Why Is Nuvoco Vistas Corporation Share Price Falling Key Reasons 2026

Why Is Capacite Infraprojects Share Price Falling Key Reasons 2026

Why Is PSP Projects Share Price Falling Key Reasons 2026



News Share Price Target
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply